Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154087 · ClinicalTrials.gov registry record · Phase 2
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
A Phase 2 study, sponsored by Healthpoint.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02154087 is a Phase 2 study that was terminated before completion, run by Healthpoint. The registered enrollment target is 1 participants.
The verdict
NCT02154087, a Phase 2 study, was terminated before completion, sponsored by Healthpoint.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Assess the influence of HP802-247 on biochemical and cellular markers of inflammation in chronic venous leg ulcers
Interventions
- BIOLOGICAL HP802-247
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02154087
The ClinicalTrials.gov registry entry for NCT02154087 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HP802-247 is the first listed.
NCT02154087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02154087 about?
NCT02154087 is a clinical study titled "A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers". Assess the influence of HP802-247 on biochemical and cellular markers of inflammation in chronic venous leg ulcers
What is the current status of trial NCT02154087?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2014-07. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02154087?
The interventions under investigation include: HP802-247 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02154087?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.